CompanyGraph
Hunan Sundy Science and Technology Co., Ltd.
300515 · SZSE · China
sandegroup.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 4 incoming connections
- PositionOperating margin is 34.5%, higher than 95% of its Scientific & Technical Instruments peers (median 8.9%)
- FinancialsAltman Z-Score 5.35: safe zone
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.56%Above 5Y avg (1.46%)
Annual Rate
CNY 0.40Paid annual
Payout Ratio
38.3%Sustainable
Payback Period
40.3 yr
Last Ex-Dividend
Jun 4, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.22BCNY480.19M · vs all stocks (USD)
Trailing P/E
15.04xvs Scientific & Technical Instruments peers
Revenue (TTM)
708.62MCNY105.74M · vs all stocks (USD)
Profit Margin
29.62%vs Scientific & Technical Instruments peers
Beta
0.6390xvs all stocks
52-Week Change
-24.70%vs all stocks
Market Capitalization
3.22BCNY480.19M · vs all stocks (USD)
Enterprise Value
2.80BCNY417.13M · vs all stocks (USD)
Trailing P/E
15.04xvs Scientific & Technical Instruments peers
Forward P/E
17.57xvs Scientific & Technical Instruments peers
Price to Sales (TTM)
4.54xvs Scientific & Technical Instruments peers
Price to Book (MRQ)
3.34xvs Scientific & Technical Instruments peers
Enterprise to Revenue
3.94xvs Scientific & Technical Instruments peers
Enterprise to EBITDA
12.08xvs Scientific & Technical Instruments peers
Gross Margin
56.66%vs Scientific & Technical Instruments peers
Profit Margin
29.62%vs Scientific & Technical Instruments peers
Operating Margin
34.50%vs Scientific & Technical Instruments peers
Return on Assets (TTM)
9.93%vs Scientific & Technical Instruments peers
Return on Equity (TTM)
23.65%vs Scientific & Technical Instruments peers
Revenue (TTM)
708.62MCNY105.74M · vs all stocks (USD)
Revenue per Share (TTM)
3.53CNYUpdated Sep 20, 2026Quarterly Revenue Growth
20.70%vs Scientific & Technical Instruments peers
Gross Profit (TTM)
379.50MCNY56.63M · vs all stocks (USD)
EBITDA (TTM)
198.82MCNY29.67M · vs all stocks (USD)
Net Income (TTM)
209.89MCNY31.32M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
63.70%vs Scientific & Technical Instruments peers
Operating Cash Flow (TTM)
226.23MCNY33.76M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
113.40MCNY16.92M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.4000CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
2.56%vs all stocks
5-Year Average Dividend Yield
1.46%vs all stocks
Payout Ratio
38.26%vs Scientific & Technical Instruments peers
Minority Interest (Equity)
15.28MCNYFY2025 · Dec 31, 2025Revenue
659.86MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
300.49MCNYFY2025 · Dec 31, 2025Gross Profit
359.37MCNYFY2025 · Dec 31, 2025Operating Income
197.90MCNY29.53M · vs all stocks (USD)
Pre-tax Income
203.62MCNYFY2025 · Dec 31, 2025Income Tax Expense
19.12MCNYFY2025 · Dec 31, 2025Net Income
184.50MCNYFY2025 · Dec 31, 2025EBIT
197.90MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
217.42MCNYFY2025 · Dec 31, 2025Research & Development
68.03MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
45.17MCNYFY2025 · Dec 31, 2025Other Operating Expenses
11.33MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
970.50KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.9147CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.9147CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
200.75MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
200.75MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
184.50MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-868.24KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
70.74MCNYFY2025 · Dec 31, 2025Free Cash Flow
66.06MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
70.48MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
184.50MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-43.51MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-70.25MCNYFY2025 · Dec 31, 2025Capital Expenditures
-4.68MCNYFY2025 · Dec 31, 2025Purchase of Investments
-808.62MCNYFY2025 · Dec 31, 2025Sale of Investments
662.65MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-150.65MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-60.60MCNYFY2025 · Dec 31, 2025Other Financing Charges
781.11KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-59.82MCNYFY2025 · Dec 31, 2025Shares Outstanding
205.75MSharesUpdated Sep 20, 2026Float Shares
94.93MSharesUpdated Sep 20, 2026% Held by Insiders
57.71%vs all stocks
% Held by Institutions
1.08%vs all stocks
Total Cash (MRQ)
360.44MCNY53.79M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.79CNYUpdated Sep 20, 2026Total Debt (MRQ)
0.00CNYvs all stocks (USD)
Total Debt to Equity (MRQ)
0.00xvs Scientific & Technical Instruments peers
Current Ratio (MRQ)
2.07xvs Scientific & Technical Instruments peers
Book Value per Share (MRQ)
4.68CNYUpdated Sep 20, 2026Total Assets
1.50BCNY223.09M · vs all stocks (USD)
Total Current Assets
1.14BCNYFY2025 · Dec 31, 2025Total Liabilities
549.04MCNYFY2025 · Dec 31, 2025Total Non-current Assets
351.27MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.95MCNYFY2025 · Dec 31, 2025Total Current Liabilities
547.09MCNYFY2025 · Dec 31, 2025Cash
70.48MCNYFY2025 · Dec 31, 2025Cash Equivalents
46.10MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
116.58MCNYFY2025 · Dec 31, 2025Other Short-term Investments
374.39MCNYFY2025 · Dec 31, 2025Accounts Receivable
228.50MCNYFY2025 · Dec 31, 2025Inventory
269.60MCNYFY2025 · Dec 31, 2025Accounts Payable
139.23MCNYFY2025 · Dec 31, 2025Other Current Liabilities
55.89MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
1.13MCNYFY2025 · Dec 31, 2025Common Stock (Book)
205.75MCNYFY2025 · Dec 31, 2025Retained Earnings
510.52MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
946.01MCNY141.16M · vs all stocks (USD)
Treasury Stock
43.02MCNYFY2025 · Dec 31, 202552-Week Low
12.27CNYUpdated Sep 20, 202652-Week High
23.91CNYUpdated Sep 20, 202652-Week Change
-24.70%vs all stocks
Beta
0.6390xvs all stocks
50-Day MA
15.48CNYUpdated Sep 20, 2026200-Day MA
17.43CNYUpdated Sep 20, 2026Avg 10-Day Volume
2.41MSharesUpdated Sep 20, 2026Avg 30-Day Volume
4.35MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
1.04CNYUpdated Sep 20, 20266 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion Levels
Its gross margin and its cash margin are high for its industry, and its operating margin is high outright.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Net Levels
Its gross and net margins are high for its industry, and its operating margin is high outright.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 34.5%, higher than 95% of its Scientific & Technical Instruments peers (median 8.9%)Significant
Operating margin: 0.35Industry median: 0.09Industry P95: 0.23Peers compared: 64.00
Profit margin is 29.6%, higher than 95% of its Scientific & Technical Instruments peers (median 6.4%)Significant
Profit margin: 0.30Industry median: 0.06Industry P95: 0.21Peers compared: 64.00
Return on equity is 23.7%, higher than 95% of its Scientific & Technical Instruments peers (median 4.1%)Significant
Return on equity: 0.24Industry median: 0.04Industry P95: 0.20Peers compared: 64.00
Debt-to-equity is 0×, lower than 95% of its Scientific & Technical Instruments peers (median 0.13×)Notable
Debt-to-equity: 0.00Industry median: 0.13Industry P5: 0.01Peers compared: 64.00
Financial Health
Altman Z-Score 5.35: safe zoneNotable
Altman Z-Score: 5.35
Supply Chain
Midstream position: 6 outgoing, 4 incoming connectionsNotable
Outgoing: 6.00Incoming: 4.00
High connectivity hub: 10 industry connectionsNotable
Total Connections: 10.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Bosun Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Shenzhen Zowee Tech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Skymoons Technology
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Dalian Zhiyun Automation Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Shanghai Xuerong Bio-Tech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRisk
Shanghai Hollywave Electronic System Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Jiangsu Huifeng Bio Agriculture Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Guangdong Zhengye Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Well Lead Medical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Jiangxi Wannianqing Cement Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Xiamen Amoytop Biotech Co., Ltd.
6 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsCash Backing With Revenue And Income StreaksRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net Levels
Classys Inc.
6 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsCash Backing With Revenue And Income StreaksRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net Levels
Krafton Inc.
6 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsCash Backing With Revenue And Income StreaksRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net Levels